Leveraging electronic health records and knowledge networks for Alzheimer's disease prediction and sex-specific biological insights
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
Identification of Alzheimer’s disease (AD) onset risk can facilitate interventions before irreversible disease progression. We demonstrate that electronic health records from the University of California, San Francisco, followed by knowledge networks (for example, SPOKE) allow for (1) prediction of AD onset and (2) prioritization of biological hypotheses, and (3) contextualization of sex dimorphism. We trained random forest models and predicted AD onset on a cohort of 749 individuals with AD and 250,545 controls with a mean area under the receiver operating characteristic of 0.72 (7 years prior) to 0.81 (1 day prior). We further harnessed matched cohort models to identify conditions with predictive power before AD onset. Knowledge networks highlight shared genes between multiple top predictors and AD (for example, APOE , ACTB , IL6 and INS ). Genetic colocalization analysis supports AD association with hyperlipidemia at the APOE locus, as well as a stronger female AD association with osteoporosis at a locus near MS4A6A . We therefore show how clinical data can be utilized for early AD prediction and identification of personalized biological hypotheses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These technologies can capture multi-domain clinical data reflecting cognitive, behavioral, social, and physical function without any added patient burden, allowing for the development of digital biomarkers of ADRD.110”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [110]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the population level, ML and AI can identify high-risk subgroups and distinct disease trajectories associated with specific combinations of early life exposures, socioeconomic factors, and health behaviors [4, 9, 16, 30, 31].”
From Integrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“By integrating neuroimaging, genetic, and clinical data, researchers have developed models that can identify individuals at high risk of developing Alzheimer’s disease [15–18].”
From Integrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions (2024) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · cited 1×
“…features (age, first visit age, years in EHR, log(number of prior visits), log(number of prior concepts), log(days since first clinical event)) utilizing propensity score matching 87 (propensity score estimated based upon a logistic regression model, nearest-neighbor matching without replacement).”
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“In particular, APOE is a well-established associated genetic locus 70 , and APOE polymorphism is known to modify AD risk, particularly in individuals carrying the ε4 allele 71 .”
Scikit-learn: Machine Learning in Python
(2011) · Journal of Machine Learning Research · doi:10.5555/1953048.2078195 · Cited by 8,539
Giambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
Self-citation2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
The reactome pathway knowledgebase 2022
Gillespie, M., Jassal, B., Stephan, R., Milacic, M., Rothfels, K., Senff-Ribeiro, A., Griss, J., Sevilla, C., Matthews, L., Gong, C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1028 · Cited by 2,339
Genomic atlas of the human plasma proteome
Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268 · cited 1×
“100,101.”
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Computing topological parameters of biological networks
Assenov, Y., Ramírez, F., Schelhorn, S.-E., Lengauer, T., & Albrecht, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm554 · Cited by 1,826
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Connecting genetic risk to disease end points through the human blood plasma proteome
Suhre, K., Arnold, M., Bhagwat, A. M., Cotton, R. J., Engelke, R., Raffler, J., Sarwath, H., Thareja, G., Wahl, A., DeLisle, R. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14357 · Cited by 800
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785 · cited 1×
“48).”
An atlas of genetic influences on osteoporosis in humans and mice
23andMe Research Team, Morris, J. A., Kemp, J. P., Youlten, S. E., Laurent, L., Logan, J. G., Chai, R. C., Vulpescu, N. A., Forgetta, V., Kleinman, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0302-x · Cited by 773
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666 · cited 2×
“Heterogeneous knowledge networks provide an opportunity to prioritize biological hypotheses from clinical data by synthesizing knowledge across multiple data modalities to explain relationships between many shared clinical associations 28,29 .”
Self-citationSex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643
Ghoussaini, M., Mountjoy, E., Carmona, M., Peat, G., Schmidt, E. M., Hercules, A., Fumis, L., Miranda, A., Carvalho-Silva, D., Buniello, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa840 · Cited by 615
Mountjoy, E., Schmidt, E. M., Carmona, M., Schwartzentruber, J., Peat, G., Miranda, A., Fumis, L., Hayhurst, J., Buniello, A., Karim, M. A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00945-5 · Cited by 581 · cited 1×
“We further explored the association between clinical predictors and AD by identifying shared genetic loci between top model phenotypes and AD, based on colocalization probability and weighted evidence association scores computed from Open Targets Genetics 98,99 (https:// genetics.opentargets.org/).”
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18 F-FDG PET of the Brain
Ding, Y., Sohn, J. H., Kawczynski, M. G., Trivedi, H., Harnish, R., Jenkins, N. W., Lituiev, D., Copeland, T. P., Aboian, M. S., Mari Aparici, C., et al. (2019) · Radiology · doi:10.1148/radiol.2018180958 · Cited by 577
Vitamin D and the risk of dementia and Alzheimer disease
Littlejohns, T. J., Henley, W. E., Lang, I. A., Annweiler, C., Beauchet, O., Chaves, P. H. M., Fried, L., Kestenbaum, B. R., Kuller, L. H., Langa, K. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000755 · Cited by 572
Schwartzentruber, J., Cooper, S., Liu, J. Z., Barrio-Hernandez, I., Bello, E., Kumasaka, N., Young, A. M. H., Franklin, R. J. M., Johnson, T., Estrada, K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00776-w · Cited by 532
Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation
Wu, P., Gifford, A., Meng, X., Li, X., Campbell, H., Varley, T., Zhao, J., Carroll, R., Bastarache, L., Denny, J. C., et al. (2019) · JMIR Medical Informatics · doi:10.2196/14325 · Cited by 515
Alzheimer’s Disease – Why We Need Early Diagnosis
Rasmussen, J., & Langerman, H. (2019) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s228939 · Cited by 501
Opening the black box: interpretable machine learning for geneticists
Azodi, C. B., Tang, J., & Shiu, S.-H. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.03.005 · Cited by 473
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443 · cited 1×
“Another example insight includes INS as a shared association between osteoporosis 58 , hypertension 59 , HLD 60 and AD 61,62 .”
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4f6 · Cited by 328
Wallace, L. M. K., Theou, O., Godin, J., Andrew, M. K., Bennett, D. A., & Rockwood, K. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30371-5 · Cited by 310
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Deming, Y., Filipello, F., Cignarella, F., Cantoni, C., Hsu, S., Mikesell, R., Li, Z., Del-Aguila, J. L., Dube, U., Farias, F. G., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau2291 · Cited by 271 · cited 1×
“Some studies investigating the role of the MS4A family suggest mechanisms that involve immune function, particularly among microglia 79 .”
Kojima, G., Taniguchi, Y., Iliffe, S., & Walters, K. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.05.013 · Cited by 261
Genome-wide association studies in Alzheimer’s disease
Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257 · cited 1×
“In particular, APOE is a well-established associated genetic locus 70 , and APOE polymorphism is known to modify AD risk, particularly in individuals carrying the ε4 allele 71 .”
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
Chang, C.-H., Lin, C.-H., & Lane, H.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052761 · Cited by 257 · cited 1×
“These include limited specificity for the AD phenotype 15 , a lack of biological interpretability, imprecise temporal information or reliance on data modalities that may not be readily available in the EHR to facilitate early prediction (for example, neuroimaging 16–18 or special biomarkers 19,20 ).”
Wang, F., Han, L., & Hu, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.009 · Cited by 247
Firearm Violence Exposure and Serious Violent Behavior
Bingenheimer, J. B., Brennan, R. T., & Earls, F. J. (2005) · Science · doi:10.1126/science.1110096 · Cited by 245 · cited 1×
“While propensity score is often utilized to balance treatment probabilities in cohort studies, it has also been utilized for sample selection 88,89 , exposure likelihood 90 or for outcome-based case–control studies 7,91 .”
Insulin Resistance in Alzheimer's Disease
Ferreira, L. S. S., Fernandes, C. S., Vieira, M. N. N., & De Felice, F. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 228
Using Phecodes for Research with the Electronic Health Record: From PheWAS to PheRS
Bastarache, L. (2021) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122320-112352 · Cited by 213
Mutations in the γ-Actin Gene (ACTG1) Are Associated with Dominant Progressive Deafness (DFNA20/26)
Zhu, M., Yang, T., Wei, S., DeWan, A. T., Morell, R. J., Elfenbein, J. L., Fisher, R. A., Leal, S. M., Smith, R. J. H., & Friderici, K. H. (2003) · The American Journal of Human Genetics · doi:10.1086/379286 · Cited by 201
Dyslipidemia and the Risk of Alzheimer’s Disease
Reitz, C. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0307-3 · Cited by 190
Diogo, V. S., Ferreira, H. A., Prata, D., & Initiative, F. T. A. D. N. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01047-y · Cited by 184
Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow, R. H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.021 · Cited by 173
Effect of data leakage in brain MRI classification using 2D convolutional neural networks
Yagis, E., Atnafu, S. W., García Seco de Herrera, A., Marzi, C., Scheda, R., Giannelli, M., Tessa, C., Citi, L., & Diciotti, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-01681-w · Cited by 161 · cited 1×
“Cohort selection and data preprocessing is a crucial first step to identify available clinical measures and optimal ground truth that is close to biological AD and avoid overly optimistic model performance due to nonspecific AD or improper data preprocessing 36 .”
Goveas, J. S., Espeland, M. A., Woods, N. F., Wassertheil‐Smoller, S., & Kotchen, J. M. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03233.x · Cited by 154
Park, J. H., Cho, H. E., Kim, J. H., Wall, M. M., Stern, Y., Lim, H., Yoo, S., Kim, H. S., & Cha, J. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0256-0 · Cited by 145
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3391 · Cited by 140
HFE Gene Variants Affect Iron in the Brain1–3
Nandar, W., & Connor, J. R. (2011) · Journal of Nutrition · doi:10.3945/jn.110.130351 · Cited by 135
Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis
Sáiz-Vazquez, O., Puente-Martínez, A., Ubillos-Landa, S., Pacheco-Bonrostro, J., & Santabárbara, J. (2020) · Brain Sciences · doi:10.3390/brainsci10060386 · Cited by 135 · cited 1×
“The association between HLD and AD has been identified in prior clinical studies and systematic reviews 66–69 .”
Stamate, D., Kim, M., Proitsi, P., Westwood, S., Baird, A., Nevado‐Holgado, A., Hye, A., Bos, I., Vos, S. J. B., Vandenberghe, R., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.11.001 · Cited by 132
Alzheimer's Disease: Diagnosis and Treatment Across the Spectrum of Disease Severity
Neugroschl, J., & Wang, S. (2011) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20279 · Cited by 131
Mild to moderate Alzheimer dementia with insufficient neuropathological changes
Serrano‐Pozo, A., Qian, J., Monsell, S. E., Blacker, D., Gómez‐Isla, T., Betensky, R. A., Growdon, J. H., Johnson, K. A., Frosch, M. P., Sperling, R. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24125 · Cited by 120
Taubes, A., Nova, P., Zalocusky, K. A., Kosti, I., Bicak, M., Zilberter, M. Y., Hao, Y., Yoon, S. Y., Oskotsky, T., Pineda, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00122-7 · Cited by 118
Self-citationAmyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function
Li, S., Liu, B., Zhang, L., & Rong, L. (2014) · Bone · doi:10.1016/j.bone.2014.01.010 · Cited by 117
Li, Q., Yang, X., Xu, J., Guo, Y., He, X., Hu, H., Lyu, T., Marra, D., Miller, A., Smith, G., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12967 · Cited by 113 · cited 1×
“While machine learning (ML) has been previously applied to EHRs for general dementia classification and prediction 11–14 , these approaches have limitations.”
You, J., Zhang, Y.-R., Wang, H.-F., Yang, M., Feng, J.-F., Yu, J.-T., & Cheng, W. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101665 · Cited by 104
Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease
Bowman, G. L., Kaye, J. A., & Quinn, J. F. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/184042 · Cited by 100
Morris, J. H., Soman, K., Akbas, R. E., Zhou, X., Smith, B., Meng, E. C., Huang, C. C., Cerono, G., Schenk, G., Rizk-Jackson, A., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad080 · Cited by 99 · cited 1×
“We demonstrate interpretability using heterogeneous knowledge networks (SPOKE knowledge graph) 30 and validate predictors with supporting evidence in external EHR datasets and through genetic colocalization analysis.”
Self-citationAlzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Popuri, K., Ma, D., Wang, L., & Beg, M. F. (2020) · Human Brain Mapping · doi:10.1002/hbm.25115 · Cited by 96
Polygenic risk and hazard scores for Alzheimer's disease prediction
Leonenko, G., Sims, R., Shoai, M., Frizzati, A., Bossù, P., Spalletta, G., Fox, N. C., Williams, J., the GERAD consortium, Hardy, J., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.716 · Cited by 95
(2020) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64123-6.00018-7 · Cited by 89
Predicting dementia with routine care EMR data
Ben Miled, Z., Haas, K., Black, C. M., Khandker, R. K., Chandrasekaran, V., Lipton, R., & Boustani, M. A. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.101771 · Cited by 87
Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease
Talwar, P., Silla, Y., Grover, S., Gupta, M., Agarwal, R., Kushwaha, S., & Kukreti, R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-199 · Cited by 86
Nelson, C. A., Butte, A. J., & Baranzini, S. E. (2019) · Nature Communications · doi:10.1038/s41467-019-11069-0 · Cited by 85
Self-citationDavis, E. J., Solsberg, C. W., White, C. C., Miñones-Moyano, E., Sirota, M., Chibnik, L., Bennett, D. A., De Jager, P. L., Yokoyama, J. S., & Dubal, D. B. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2806 · Cited by 78
Self-citationSample Selection in Randomized Experiments: A New Method Using Propensity Score Stratified Sampling
Tipton, E., Hedges, L., Vaden-Kiernan, M., Borman, G., Sullivan, K., & Caverly, S. (2014) · Journal of Research on Educational Effectiveness · doi:10.1080/19345747.2013.831154 · Cited by 77
Alzheimer's disease and osteoporosis
Lo, R. Y., & Chen, Y. (2017) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_54_17 · Cited by 75
Niculescu, A. B., Le-Niculescu, H., Roseberry, K., Wang, S., Hart, J., Kaur, A., Robertson, H., Jones, T., Strasburger, A., Williams, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0602-2 · Cited by 75
Elbejjani, M., Fuhrer, R., Abrahamowicz, M., Mazoyer, B., Crivello, F., Tzourio, C., & Dufouil, C. (2015) · Psychological Medicine · doi:10.1017/s0033291714003055 · Cited by 73
Relationship between frailty and Alzheimer's disease biomarkers: a scoping review
Wallace, L., Theou, O., Rockwood, K., & Andrew, M. K. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.05.002 · Cited by 72
Sex-dependent autosomal effects on clinical progression of Alzheimer’s disease
Fan, C. C., Banks, S. J., Thompson, W. K., Chen, C.-H., McEvoy, L. K., Tan, C. H., Kukull, W., Bennett, D. A., Farrer, L. A., Mayeux, R., et al. (2020) · Brain · doi:10.1093/brain/awaa164 · Cited by 69
Hampel, H., Vergallo, A., Giorgi, F. S., Kim, S. H., Depypere, H., Graziani, M., Saidi, A., Nisticò, R., & Lista, S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.001 · Cited by 68
Goldstein, F. C., Ashley, A. V., Endeshaw, Y. W., Hanfelt, J., Lah, J. J., & Levey, A. I. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318188e80d · Cited by 62
Tan, C., Meng, L., Lv, M., He, X., Sha, Y., Tang, D., Tan, Y., He, W., He, W., Tu, C., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.022 · Cited by 61
Revealing cell vulnerability in Alzheimer’s disease by single-cell transcriptomics
Saura, C. A., Deprada-Fernandez, Á., Capilla-López, M. D., & Parra‐Damas, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.05.007 · Cited by 61
Garcia, A. R., Finch, C., Gatz, M., Kraft, T., Eid Rodriguez, D., Cummings, D., Charifson, M., Buetow, K., Beheim, B. A., Allayee, H., et al. (2021) · eLife · doi:10.7554/elife.68231 · Cited by 60
Belonwu, S. A., Li, Y., Bunis, D., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 55
Self-citationVasilopoulos, Y., Gkretsi, V., Armaka, M., Aidinis, V., & Kollias, G. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.079822 · Cited by 51
High prevalence of dementia in women with osteoporosis
Amouzougan, A., Lafaie, L., Marotte, H., Dẻnariẻ, D., Collet, P., Pallot-Prades, B., & Thomas, T. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.08.002 · Cited by 51 · cited 1×
“The association between osteoporosis and AD is also validated to a lesser extent in clinical studies and meta-analysis 75,76 , with unclear but possible sex modification of this effect.”
Nelson, C. A., Bove, R., Butte, A. J., & Baranzini, S. E. (2022) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab270 · Cited by 50
Self-citationTang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45
Self-citationChalak, L. F., Pappas, A., Tan, S., Das, A., Sánchez, P. J., Laptook, A. R., Meurs, K. P. V., Shankaran, S., Bell, E. F., Davis, A. S., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3723 · Cited by 44
Walling, A. M., Pevnick, J. M., Bennett, A. V., Vydiswaran, V. G. V., & Ritchie, C. S. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad086 · Cited by 41
Xu, J., Wang, F., Xu, Z., Adekkanattu, P., Brandt, P., Jiang, G., Kiefer, R. C., Luo, Y., Mao, C., Pacheco, J. A., et al. (2020) · Learning Health Systems · doi:10.1002/lrh2.10246 · Cited by 38
He, Z., Guen, Y. L., Liu, L., Lee, J., Ma, S., Yang, A. C., Liu, X., Rutledge, J., Losada, P. M., Song, B., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.10.009 · Cited by 32
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-99352-3 · Cited by 30
Ataie-Ashtiani, S., & Forbes, B. E. (2023) · Cells · doi:10.3390/cells12071008 · Cited by 25
Lv, X.-L., Zhang, J., Gao, W.-Y., Xing, W.-M., Yang, Z.-X., Yue, Y.-X., Wang, Y.-Z., & Wang, G.-F. (2018) · International Journal of Gerontology · doi:10.1016/j.ijge.2018.03.007 · Cited by 24 · cited 1×
“The association between osteoporosis and AD is also validated to a lesser extent in clinical studies and meta-analysis 75,76 , with unclear but possible sex modification of this effect.”
Kim, Y., Jiang, X., Giancardo, L., Peña, D., Bukhbinder, A. S., Amran, A. Y., Schulz, P. E., & Initiative, A. D. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-62263-w · Cited by 23
Xia, Y., Gu, Y., Yu, F., Zhang, Q., Liu, L., Meng, G., Wu, H., Du, H., Shi, H., Guo, X., et al. (2016) · Scientific Reports · doi:10.1038/srep34748 · Cited by 20
Tang, A., Woldemariam, S. R., Roger, J. M., & Sirota, M. (2022) · Yearbook of Medical Informatics · doi:10.1055/s-0042-1742513 · Cited by 19
Self-citationLiew, T. M. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221079217 · Cited by 18
Iivonen, S., Helisalmi, S., Mannermaa, A., Alafuzoff, I. I., Lehtovirta, M., Soininen, H. S., & Hiltunen, M. O. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.041 · Cited by 17
Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care
Gale, S. A., Heidebrink, J. L., Grill, J. D., Graff‐Radford, J., Jicha, G. A., Menard, W. E., Nowrangi, M. A., Sami, S. A., Sirivong, S., Walter, S., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201347 · Cited by 16
Park, J. H., Cho, H. E., Kim, J. H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/625582 · Cited by 15
Rahman, S. O., Khan, T. M., Iqubal, A., Agarwal, S., Akhtar, M., Parvez, S., Shah, Z. A., & Najmi, A. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121899 · Cited by 15
Talwar, P., Kushwaha, S. S., Rawat, C., Kaur, H., Srivastava, A., Agarwal, R., Chandna, P., Tucci, P., Saso, L., & Kukreti, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.722221 · Cited by 11
Savonenko, A. V., Wong, P. C., & Li, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00022-8 · Cited by 9
Liu, Y., Jin, G., Wang, X., Dong, Y., & Ding, F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.728563 · Cited by 6
Kimura, R., Kamino, K., Yamamoto, M. L., Kida, T., Akatsu, H., Uema, T., Kobayashi, T., HATTORI, H., Nuripa, A., Begum, N. N., et al. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01525.x-i1 · Cited by 4
Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., et al. (2018) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 4
Karlin, L., Arnulf, B., Chevret, S., Robin, M., de Latour, R. P., Malphettes, M., Kabbara, N., Asli, B., Adès, L., Rocha, V., et al. (2008) · Blood · doi:10.1182/blood.v112.11.1133.1133 · Cited by 2
Cited by
Biomedical knowledge graph-optimized prompt generation for large language models
Soman, K., Rose, P. W., Morris, J. H., Akbas, R. E., Smith, B., Peetoom, B., Villouta-Reyes, C., Cerono, G., Shi, Y., Rizk-Jackson, A., et al. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae560 · Cited by 135
Self-citationLi, R., Wang, X., Berlowitz, D. R., Mez, J., Lin, H., & Yu, H. Z. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01940-4 · Cited by 91
Harnessing EHR data for health research
Tang, A. S., Woldemariam, S. R., Miramontes, S., Norgeot, B., Oskotsky, T. T., & Sirota, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03074-8 · Cited by 87
“Excitingly, augmentation of clinical phenotypes with known disease—molecular associations from heterogeneous knowledge databases is emerging as a promising opportunity for generating and prioritizing biological hypotheses—as evidenced by recent efforts in multiple sclerosis and AD 45,46 .”
InfluentialSelf-citationChen, S., Yu, J., Chamouni, S., Wang, Y., & Li, Y. (2024) · BMC Medicine · doi:10.1186/s12916-024-03566-x · Cited by 73
“At the population level, ML and AI can identify high-risk sub-groups and distinct disease trajectories associated with specific combinations of early life exposures, socioeconomic factors, and health behaviors [4, 9, 16, 30, 31].”
BackgroundSelf-citationUtilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Ren, Y., Pieper, A. A., & Cheng, F. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00553 · Cited by 61
Metadata
- Authors
- Tang, A. S., Rankin, K. P., Cerono, G., Miramontes, S., Mills, H., Roger, J., Zeng, B., Nelson, C., Soman, K., Woldemariam, S., Li, Y., Lee, A., Bove, R., Glymour, M., Aghaeepour, N., Oskotsky, T. T., Miller, Z., Allen, I. E., Sanders, S. J., Baranzini, S., & Sirota, M.
- Affiliations
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Corresponding author
- Tang, Alice S.
- Sirota, Marina
- ORCID
- Tang, Alice S.
- Rankin, Katherine P.
- Cerono, Gabriel
- Miramontes, Silvia
- Mills, Hunter
- Roger, Jacquelyn
- Zeng, Billy
- Nelson, Charlotte
- Soman, Karthik
- Woldemariam, Sarah
- Li, Yaqiao
- Bove, Riley
- Glymour, Maria
- Aghaeepour, Nima
- Oskotsky, Tomiko T.
- Miller, Zachary
- Allen, Isabel E.
- Sanders, Stephan J.
- Baranzini, Sergio
- Sirota, Marina
- Venue
- Nature Aging
- Published
- 2024-02-21
- Volume
- 4
- Issue
- 3
- Pages
- 379-395
- ISSN
- 2662-8465 (ISSN-L)
- PMC
- PMC10950787
- OpenAlex
- W4392003803
- Cited by
- 86
- References
- 106
- Citations by year
- 2026: 31 · 2025: 42 · 2024: 13
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Aging (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (R01AG060393, T32GM007618, P30-AG062422, R35GM138353 and RF1AG077443.)
- National Multiple Sclerosis Society
- National Science Foundation
- Heidrich Family and Friends Endownment
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, electronic health records, knowledge networks, sex differences, sexual dimorphism, apolipoprotein E, hyperlipidemia, osteoporosis, MS4A6A, genetic colocalization, shared genetic risk
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Female, Humans, Male, San Francisco, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.